Authors’ Response to Yoshihiro Noguchi’s Comment on: “A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)”.
-
アブストラクト ジャーナル名 Drug safety 投稿日 2022/10/13 投稿者 Malone, Daniel C; Villa-Zapata, Lorenzo; Gomez-Lumbreras, Ainhoa; Horn, John; Tan, Malinda S; Boyce, Richard D 組織名 Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake;City, UT, USA. dan.malone@utah.edu.;Department of Pharmacy Practice, College of Pharmacy, Mercer University, Atlanta,;GA, USA.;City, UT, USA.;Department of Pharmacy, School of Pharmacy, University of Washington, Seattle,;WA, USA.;Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA,;USA. Pubmed リンク https://www.ncbi.nlm.nih.gov/pubmed/36223037/ -
お問合わせ
検索
メルマガ登録
